The role of acid suppressants in upper gastrointestinal ulcer bleeding

Best Practice and Research: Clinical Gastroenterology

Volumn 15, Issue 3, 2001, Pages 463-475

  Van Leerdam, Monique E ^a   Rauws, Erik A J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Acid secretion; H2 receptor antagonists; Peptic ulcer haemorrhage; Proton pump inhibitor

Indexed keywords

BENZIMIDAZOLE DERIVATIVE; CIMETIDINE; ESOMEPRAZOLE; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; NIZATIDINE; OMEPRAZOLE; PANTOPRAZOLE; PLACEBO; PROTON PUMP INHIBITOR; RABEPRAZOLE; RANITIDINE; SOMATOSTATIN; STOMACH SECRETION INHIBITOR;

ABDOMINAL SURGERY; ARTICLE; BLOOD CLOTTING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIGESTIVE SYSTEM HEMORRHAGE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG HALF LIFE; DRUG MECHANISM; DUODENUM ULCER; ENDOSCOPIC THERAPY; GASTROINTESTINAL HEMORRHAGE; HUMAN; IN VITRO STUDY; MORTALITY; MULTICENTER STUDY; PEPTIC ULCER; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; STOMACH PH; STOMACH ULCER; TACHYPHYLAXIS; THROMBOCYTE FUNCTION; TREATMENT OUTCOME;

EID: 0034961676     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1053/bega.2000.0194     Document Type: Article

References (47)

1. Epidemiology and course of acute upper gastro-intestinal haemorrhage in four French geographical areas
2. Epidemiology of hospitalization for acute upper gastrointestinal hemorrhage: A population-based study
3. A randomized comparative study of laser photocoagulation, heater probe, and bipolar electrocoagulation in the treatment of actively bleeding ulcers
4. Bleeding peptic ulcer
5. Prediction of further hemorrhage in bleeding peptic ulcer
6. Acute upper gastrointestinal bleeding in the Amsterdam area: Incidence, diagnosis, and clinical outcome
7. Risk assessment after acute upper gastrointestinal haemorrhage
8. Factors related to the failure of endoscopic injection therapy for bleeding gastric ulcer
9. How efficient is endoscopic injection sclerotherapy in peptic ulcer hemorrhage
10. Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhage: A meta-analysis
11. Therapeutic endoscopy and bleeding ulcers
12. Effect of acid and pepsin on blood coagulation and platelet aggregation. A possible contributor to prolonged gastroduodenal mucosal hemorrhage
13. Clot lysis by gastric juice: An in vitro study
14. The effect of pH on platelet and coagulation factor activities
15. Fibrinolytic activity of gastroduodenal secretion - A possible role in upper gastrointestinal haemorrhage
16. Do continuous infusions of omeprazole and ranitidine retain their effect with prolonged dosing?
17. Efficacy of primed infusions with high dose ranitidine and omeprazole to maintain high intragastric pH in patients with peptic ulcer bleeding: A prospective randomised controlled study
18. Effect of repeated injection and continuous infusion of omeprazole and ranitidine on intragastric pH over 72 hours
19. Treatment with histamine H2 antagonists in acute upper gastrointestinal hemorrhage. Implications of randomized trials
20. Continuous intravenous famotidine for haemorrhage from peptic ulcer
21. Acid suppression in peptic ulcer haemorrhage: A 'meta-analysis'
22. Review article: The pharmacological inhibition of gastric acid secretion-tolerance and rebound
23. Review article: Pharmacokinetic concerns in the selection of anti-ulcer therapy
24. Pharmacokinetics and drug interactions - Relevant factors for the choice of a drug
25. Pantoprazole. A review of its pharmacological properties and therapeutic use in acid-related disorders
26. Inhibition of the gastric acid pump
27. Effect of intravenous and oral omeprazole on 24-hour intragastric acidity in duodenal ulcer patients
28. Effect of repeated boluses of intravenous omeprazole and primed infusions of ranitidine on 24-hour intragastric pH in healthy human subjects
29. Optimizing the intragastric pH as a supportive therapy in upper GI bleeding
30. Effect of intravenous infusion of omeprazole and ranitidine on twenty-four-hour intragastric pH in patients with a history of duodenal ulcer
31. Intravenous therapy with high doses of ranitidine and omeprazole in critically ill patients with bleeding peptic ulcerations of the upper intestinal tract: An open randomized controlled trial
32. Omeprazole versus placebo for acute upper gastrointestinal bleeding: Randomised double blind controlled trial
33. Non-bleeding visible vessel treatment: Perendoscopic injection therapy versus omeprazole infusion
34. Effect of parenteral omeprazole and ranitidine on gastric pH and the outcome of bleeding peptic ulcer
35. Omeprazole versus ranitidine as adjunct therapy to endoscopic injection in actively bleeding ulcers: A prospective and randomized study
36. Somatostatin in the prevention of recurrent bleeding after endoscopic haemostasis of peptic ulcer haemorrhage: A preliminary report
37. Omeprazole versus ranitidine plus somatostatin in the treatment of severe gastroduodenal bleeding: A prospective, randomized, controlled trial
38. Continuous intravenous infusion of omeprazole in elderly patients with peptic ulcer bleeding. Results of a placebo-controlled multicenter study
39. Effect of omeprazole on the outcome of endoscopically treated bleeding peptic ulcers. Randomized double-blind placebo-controlled multicentre study
40. A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopic therapy
41. The influence of intravenous omeprazole on intragastric pH and outcomes in patients with peptic ulcer bleeding after successful endoscopic therapy - A prospective randomized comparative trial
42. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers
43. A comparison of omeprazole and placebo for bleeding peptic ulcer
44. Tratamiento de la hemorragia digestiva alta de origen peptico: Ranitidina intravenosa versus omeprazol intravenoso
45. Omeprazol y cimetidina en el tratamiento de la hemorragia digestiva alta
46. Afecta a la evolucion de la hemorragia digestiva alta el antisecretor utilizado?
47. Nonvariceal upper gastrointestinal bleeding: Differences in outcome for patients admitted to internal medicine and gastroenterological services